These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7824322)
1. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa]. Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322 [TBL] [Abstract][Full Text] [Related]
2. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. Jaffar-Bandjee MC; Lazdunski A; Bally M; Carrère J; Chazalette JP; Galabert C J Clin Microbiol; 1995 Apr; 33(4):924-9. PubMed ID: 7790462 [TBL] [Abstract][Full Text] [Related]
3. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007 [TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa and cystic fibrosis: correlation between exoenzyme production and patient's clinical state. Lanotte P; Mereghetti L; Lejeune B; Massicot P; Quentin R Pediatr Pulmonol; 2003 Nov; 36(5):405-12. PubMed ID: 14520723 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
6. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072 [TBL] [Abstract][Full Text] [Related]
9. Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis. Jaffar-Bandjee MC; Carrère J; Bally M; Guy-Crotte O; Galabert C Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):893-9. PubMed ID: 7696436 [TBL] [Abstract][Full Text] [Related]
11. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Reid DW; Carroll V; O'May C; Champion A; Kirov SM Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792 [TBL] [Abstract][Full Text] [Related]
12. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes. Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154 [TBL] [Abstract][Full Text] [Related]
13. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa]. Reinert P Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [TBL] [Abstract][Full Text] [Related]
15. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Bradbury R; Champion A; Reid DW Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887 [TBL] [Abstract][Full Text] [Related]
16. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients. Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827 [TBL] [Abstract][Full Text] [Related]
17. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis. Bauernfeind A; Przyklenk B Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748 [No Abstract] [Full Text] [Related]
18. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
19. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960 [TBL] [Abstract][Full Text] [Related]